New report reveals global decrease in antimicrobial use in animals

New national action plan on antimicrobial resistance launched to protect people and animals from the risks of drug-resistant infections.

The initiative aims to provide countries with policy support and knowledge sharing to help reduce the need for antimicrobials in livestock production.

The U.S. Food and Drug Administration’s Center for Veterinary Medicine published the 2022 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.

The plan provides stakeholders with a transparent roadmap of the actions that correspond to FDA’s three main veterinary stewardship goals.

The recommendation seeks to encourage the prudent use of antimicrobials in humans and animals through a series of voluntary measures.

Findings from the European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021.

Sales of medically important antimicrobial drugs for use in swine were up 3% from 2020.

FDA launches interactive summary of biomass-adjusted antimicrobial sales data in food animals.

The Committee for Veterinary Medicinal Products has proposed a new working group to replace the voluntary European Surveillance of Veterinary Antimicrobial Consumption network.

These are the findings of EFSA’s scientific opinion assessing the risk of spread of antimicrobial resistance among livestock during transport.